You are here

  • Home
  • Archive
  • Volume 73, Issue 3
  • Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: a EULAR extension of STROBE guidelines based on experience from biologics registries

Article Text

Article menu
Download PDFPDF
Letter
Launch of a checklist for reporting longitudinal observational drug studies in rheumatology: a EULAR extension of STROBE guidelines based on experience from biologics registries

https://doi.org/10.1136/annrheumdis-2013-204102

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Contributors All authors have equally contributed in the discussions about the concept of the work. JZ has written the manuscript, WGD and JA have critically reviewed the manuscript, and all three authors have agreed to authorship.

    • Competing interests None.

    • Provenance and peer review Not commissioned; externally peer reviewed.